The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given a positive scientific opinion for Roche’s new immunotherapy, atezolizumab, which is accessible for patients with an incurable form of bladder cancer.
US-based SRI International has been contracted by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases and the Division of AIDS (NIAID-DAIDS) to provide development and manufacturing support for HIV microbicides and other non-vaccine pre-exposure (PreP) agents.
A study conducted by German healthcare company Fresenius Kabi has revealed that more than 75% of critically ill patients in Latin American hospitals are either malnourished or at risk of becoming malnourished.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
GlaxoSmithKline (GSK) has submitted a biologics licence application to the US Food and Drug Administration (FDA) for approval of its candidate shingles vaccine, Shingrix, to help prevent herpes zoster (shingles) in people aged 50 years or more.